If you've experienced any of these serious complications after taking a GLP-1 medication, it's vital to document your symptoms and seek immediate medical attention
Ozempic has gained in popularity due to off-label use, meaning its use for conditions not directly tested in a clinical trial or not approved by the FDA
A transdermal GLP-1 Support Patch delivers ingredients through the skin using an adhesive patch, providing steady, controlled release without pills, injections, or digestive involvement
Abruptly stopping the drugs following high-dose treatment can cause withdrawal symptoms such as fatigue and depression
Glucagon-like peptide-1 : the basis of a new class of treatment for type 2 diabetes
Ozempic is a GLP-1 receptor agonist, while Mounjaro is a dual GLP-1/GIP agonist